1163 related articles for article (PubMed ID: 18626423)
1. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
2. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
4. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
Islam MS; Vernon SA; Negi A
Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
[TBL] [Abstract][Full Text] [Related]
8. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
9. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
Ozkiris A
Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
Lee SY; Yoon YH; Lee HG; Chung H; Kim JG
Am J Ophthalmol; 2006 Sep; 142(3):501-3. PubMed ID: 16935603
[TBL] [Abstract][Full Text] [Related]
12. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
[TBL] [Abstract][Full Text] [Related]
13. Cataract progression after intravitreal triamcinolone injection.
CekiƧ O; Chang S; Tseng JJ; Akar Y; Barile GR; Schiff WM
Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
16. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Figueroa MS; Contreras I; Noval S
Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
[TBL] [Abstract][Full Text] [Related]
17. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
20. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
Thompson JT
Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]